Form 4 Filing for Amgen Inc. - Officer/Director Stock Transaction

This filing details a stock transaction by Tyler Jacks, a director at Amgen Inc. On May 19, 2026, Jacks acquired 665 shares of common stock under the Amgen Inc. 2009 Director Incentive Program. These shares were granted as Restricted Stock Units (RSUs) which vested immediately. The RSUs were paid in shares of the Company's common stock on a one-to-one basis. The filing also notes that these shares include 2,975 Dividend Equivalents (DEs) granted under the same plan. These DEs are subject to a dividend reinvestment plan and are paid out in shares of common stock along with a cash payment for any fractional shares. Following this transaction, Tyler Jacks directly owns 18,284 shares of Amgen Inc. common stock. The transaction was reported on Form 4 and signed on May 21, 2026.